Carl Feldbaum - Actelion Member of the Board of Directors

Director

Mr. Carl B. Feldbaum Esq was Member of the Board of Directors of Actelion Ltd since 2005. He is Chairman of the Nominating and Governance Committee of the Company. After graduation he went to Washington in 1973 as Assistant Special Prosecutor for the Watergate special prosecution force where he served until 1975. He was President of the Biotechnology Industry Organization in Washington D.C. from its founding in 1993 to January 2005. Earlier roles concluded President and Founder of the Palomar Corporation a national security think tank in Washington D.C. He also served as Assistant to the Secretary of Energy and as Inspector General for defense intelligence in the United States Department of Defense between 1979 and 1980. In addition he acted as Chief of Staff to Senator Arlen Specter of Pennsylvania from 1988 to 1993. In 1979 he was awarded the Distinguished Civilian Service Medal by Defense Secretary Harold Brown. He is Member of the Board of Directors of Exelexis Inc. as well as Chairman of the Board of BIO Ventures for Global Health. He holds a Bachelors degree in Biology from Princeton University and a Law degree from the University of Pennsylvania Law School. since 2005.
Age 70
Tenure 19 years
Phone41 61 565 65 65
Webhttp://www.actelion.com

Actelion Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated a profit of $23.87 on every $100 spent on assets. This is very large. Similarly, it shows a return on equity (ROE) of 47.08 %, meaning that it generated $47.08 on every $100 dollars invested by stockholders. Actelion's management efficiency ratios could be used to measure how well Actelion manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Yimin GuanTianjin Capital Environmental
67
Pindong AnTianjin Capital Environmental
46
Yilin PengTianjin Capital Environmental
35
Ming DongKingdee International Software
59
Yana FuTianjin Capital Environmental
43
Jieying LiTianjin Capital Environmental
66
Zongze GaoTianjin Capital Environmental
74
Daniel GillAsure Software
53
Adrian PertierraAsure Software
45
Charles LathropAsure Software
61
Randall WaterfieldAsure Software
43
Brad BurrowsAsure Software
N/A
Jian YangKingdee International Software
37
Yinxing ChenTianjin Capital Environmental
40
Cheng WuKingdee International Software
75
Chen ZhangKingdee International Software
50
Deng ChenKingdee International Software
37
Matthew BehrentAsure Software
46
ChiaYung LiuKingdee International Software
55
Wenbo LinTianjin Capital Environmental
57
Gary BiddleKingdee International Software
63
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. Actelion [ALIOF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Actelion Leadership Team

Elected by the shareholders, the Actelion's board of directors comprises two types of representatives: Actelion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actelion. The board's role is to monitor Actelion's management team and ensure that shareholders' interests are well served. Actelion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actelion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Widman, Co-Founder
Christian Albrich, Member of the Management Board, Senior Vice President Head Global Human Resources
Walter Fischli, Senior Vice President Academia Relations
Robert Bertolini, Member of the Board of Directors
Carl Feldbaum, Member of the Board of Directors
Andre Muller, Member of the Management Board, CFO, Executive Vice President
John Greisch, Director
Rudi Frank, Senior Vice President Head Global Quality Management, Member of the Extended Executive Committee
Marian Borovsky, Sr. VP, Group General Counsel and Corporate Secretary
Werner Henrich, Member of the Board of Directors
Nicholas Franco, Member of the Management Board, Executive Vice President Chief Business Development Officer
Martine Clozel, Founder, Chief Scientific Officer, Head of Drug Discovery Pharmacology and Preclinical Devel. and Sr. VP
Juhani Anttila, Member of the Board of Directors
JeanPierre Garnier, Chairman of the Board of Directors
David Stout, Member of the Board of Directors
JeanPaul Clozel, CEO, Member of the Executive Committee, Delegate to the Board of Directors
Guy Braunstein, Member of the Management Board, Executive Vice President Head of Clinical Development
Andrew Weiss, Head of Investor Relations and Corporate Communications and Sr. VP
Herna Verhagen, Member of the Board of Directors
Michael Jacobi, Member of the Board of Directors
Jean Malo, Member of the Board of Directors
Otto Schwarz, COO and Executive VP
Roland Haefeli, Member of the Management Board, Senior Vice President Head of Investor Relations & Public Affairs
Thomas Weller, Vice President Co-Head of Drug Discovery
Peter Gruss, Member of the Board of Directors

Actelion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Actelion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Actelion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Actelion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actelion will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Schlumberger could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Schlumberger when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Schlumberger - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Schlumberger NV to buy it.
The correlation of Schlumberger is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Schlumberger moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Schlumberger NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Schlumberger can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Actelion OTC Stock

If you are still planning to invest in Actelion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Actelion's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format